FDA unlikely to rule on Merck's COVID pill before December
The decision on the drug could come in a matter of weeks.
13 across the spectrum. Choose a side on the bar to jump to it.
National story. 22 articles from 13 sources. Updated Oct 14, 2021.
How each side is putting it
Left
4 sourcesRan by 5 outlets across the spectrum· Tucson, Sioux City Journal, +1 more
The FDA could authorize the first COVID-19 pill before year's end — here's who may be eligible to take it
Ran by 3 outlets· Berkshire Eagle, St. Louis Post-Dispatch, +1 more
Center
8 sourcesRan by 5 outlets· MedicalXpress, WNYT Albany, +3 more
Pharmaceutical companies seek FDA approval for the first ever COVID-19 pill
Ran by 3 outlets· KING 5 Seattle, KENS 5 San Antonio, +1 more
Ran by 2 outlets· WHEC Rochester, NBC4 Washington
Right
1 sourceSame wire story as other sides. No original Right take here.
FDA unlikely to rule on Merck's COVID pill before December
The story so far
3 developments- Oct 11, 2021Only center coverage:Merck asks FDA to authorize promising anti-COVID pill
- Oct 12, 2021Pharmaceutical companies seek FDA approval for the first ever COVID-19 pill
- Oct 14, 2021FDA unlikely to rule on Merck's COVID pill before December
Who covered each development
Left
Center
Right
No new developments
Quiet for 1834 daysLast development · Oct 14, 2021 — FDA unlikely to rule on Merck's COVID pill before December